- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/04 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 241/04
Total number of patents in this class: 1099
10-year publication summary
|
54
|
66
|
63
|
80
|
86
|
70
|
70
|
73
|
51
|
37
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| H. Lundbeck A/S | 1247 |
22 |
| MannKind Corporation | 528 |
17 |
| The Regents of the University of California | 19918 |
16 |
| Janssen Pharmaceutica N.V. | 3392 |
13 |
| BASF SE | 20933 |
12 |
| Contemporary Amperex Technology (Hong Kong) Limited | 3546 |
12 |
| Bristol-myers Squibb Company | 4898 |
10 |
| 3m Innovative Properties Company | 17833 |
9 |
| F. Hoffmann-La Roche AG | 7925 |
8 |
| Amgen Inc. | 4074 |
8 |
| The Trustees of the University of Pennsylvania | 4322 |
8 |
| Astellas Pharma Inc. | 1088 |
8 |
| Dongguk University Industry-Academic Cooperation Foundation | 432 |
8 |
| Dice Alpha, Inc. | 18 |
8 |
| Alkermes Pharma Ireland Limited | 269 |
7 |
| Arena Pharmaceuticals, Inc. | 366 |
7 |
| Cytokinetics, Inc. | 277 |
7 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 304 |
7 |
| Arvinas Operations, Inc. | 229 |
7 |
| Merck Sharp & Dohme LLC | 3748 |
7 |
| Other owners | 898 |